Advertisement
Screener

First Command Bank Historic Quarter Change: Foreign Stocks, Reduced

First Command Bank historic quarter change: Foreign Stocks, Reduced

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 26 quarters from 2016-12-31 to 2023-06-30, First Command Bank opened 41 positions, added to 26, reduced 40 and sold out of 38.

  • Q2 2023: Stock BP; Country of operation —; Class SPONSORED ADR; Shares before 2,131.
  • Q1 2023: Stock BP; Country of operation —; Class SPONSORED ADR; Shares before 2,133.
  • Q3 2022: Stock BP; Country of operation —; Class SPONSORED ADR; Shares before 2,541.
  • Q3 2022: Stock SHEL; Country of operation —; Class SPON ADS; Shares before 581.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1693750), 26 quarters: Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-07-21); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-04-14); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-01-23); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-10-24); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-24); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-08-24); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-01-25); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-12-16); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-07-20); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-04-20); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-01-19); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-10-20); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-07-20); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-04-20); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-01-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-10-15); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-07-11); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-04-17); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-01-18); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-10-22); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-07-20); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-04-12); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-01-12); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-10-10); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-07-10); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-04-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2016-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2023BP
BP P.L.C. Sponsored ADR
SPONSORED ADR2,1311,971-160$80,850$69,557-$11,2932023-07-21
Q1 2023BP
BP P.L.C. Sponsored ADR
SPONSORED ADR2,1332,131-2$75$80,850+$80,7752023-04-14
Q3 2022BP
BP P.L.C. Sponsored ADR
SPONSORED ADR2,5412,133-408$72,000$61,000-$11,0002022-10-24
Q3 2022SHEL
Shell PLC
SPON ADS581503-78$30,000$25,000-$5,0002022-10-24
Q2 2022BP
BP P.L.C. Sponsored ADR
SPONSORED ADR3,0332,541-492$89,000$72,000-$17,0002022-08-24
Q1 2022BUD
Anheuser-Busch InBev SA/NV ADR
SPONSORED ADR6259-616$35,000$1,000-$34,0002022-08-24
Q1 2022NVS
Novartis AG
SPONSORED ADR348100-248$28,000$9,000-$19,0002022-08-24
Q1 2022VOD
Vodafone Group PLC New Sponsored ADR
SPONSORED ADR1,005732-273$15,000$12,000-$3,0002022-08-24
Q1 2022BP
BP P.L.C. Sponsored ADR
SPONSORED ADR3,2173,033-184$88,000$89,000+$1,0002022-08-24
Q3 2021BUD
Anheuser-Busch InBev SA/NV ADR
SPONSORED ADR942625-317$68,000$35,000-$33,0002021-12-16
Q3 2021PDD
Pinduoduo Inc ADR
SPONSORED ADS143121-22$18,000$11,000-$7,0002021-12-16
Q2 2021BUD
Anheuser-Busch InBev SA/NV ADR
SPONSORED ADR1,817942-875$114,000$68,000-$46,0002021-07-20
Q1 2021BUD
Anheuser-Busch InBev SA/NV ADR
SPONSORED ADR4,9801,817-3,163$348,000$114,000-$234,0002021-04-20
Q1 2021NVS
Novartis AG
SPONSORED ADR610348-262$58,000$30,000-$28,0002021-04-20
Q4 2020NIO
NIO Inc.
ChinaSPON ADS3,5901,890-1,700$76,000$92,000+$16,0002021-01-19
Q4 2020BP
BP P.L.C. Sponsored ADR
SPONSORED ADR4,1173,133-984$72,000$64,000-$8,0002021-01-19
Q4 2020VOD
Vodafone Group PLC New Sponsored ADR
SPONSORED ADR1,298732-566$18,000$12,000-$6,0002021-01-19
Q3 2020BP
BP P.L.C. Sponsored ADR
SPONSORED ADR4,4174,117-300$103,000$72,000-$31,0002020-10-20
Q2 2020BUD
Anheuser-Busch InBev SA/NV ADR
SPONSORED ADR3,8483,380-468$170,000$167,000-$3,0002020-07-20
Q1 2020BP
BP P.L.C. Sponsored ADR
SPONSORED ADR4,5274,417-110$171,000$108,000-$63,0002020-04-20
Q1 2020NVS
Novartis AG
SPONSORED ADR760610-150$72,000$50,000-$22,0002020-04-20
Q4 2019BUD
Anheuser-Busch InBev SA/NV ADR
SPONSORED ADR4,0643,848-216$387,000$315,000-$72,0002020-01-14
Q3 2019BIDU
Baidu Inc ADR
SPON ADR REP A155115-40$18,000$12,000-$6,0002019-10-15
Q1 2019VOD
Vodafone Group PLC New Sponsored ADR
SPONSORED ADR1,189932-257$23,000$17,000-$6,0002019-04-17
Q3 2018BIDU
Baidu Inc ADR
SPON ADR REP A200115-85$49,000$26,000-$23,0002018-10-22
Q2 2018BP
BP P.L.C. Sponsored ADR
SPONSORED ADR2,1862,111-75$88,620,000$96,000-$88,524,0002018-07-20
Q2 2018SONY
Sony Corp ADR
SPONSORED ADR682478-204$32,968,000$25,000-$32,943,0002018-07-20
Q2 2018TEVA
Teva Pharmaceutical Industries LTD ADR
SPONSORED ADR920765-155$15,723,000$19,000-$15,704,0002018-07-20
Q1 2018TEVA
Teva Pharmaceutical Industries LTD ADR
SPONSORED ADR1,032920-112$20,000$15,723,000+$15,703,0002018-04-12
Q4 2017BTI
British American Tobacco PLC
SPONSORED ADR495199-296$31,000$13,000-$18,0002018-01-12
Q4 2017TEVA
Teva Pharmaceutical Industries LTD ADR
SPONSORED ADR1,6371,032-605$29,000$20,000-$9,0002018-01-12
Q4 2017ERIC
Ericsson
ADR B SEK 101,000663-337$6,000$4,000-$2,0002018-01-12
Q3 2017BP
BP P.L.C. Sponsored ADR
SPONSORED ADR4,5521,927-2,625$157,000$74,000-$83,0002017-10-10
Q3 2017TEVA
Teva Pharmaceutical Industries LTD ADR
SPONSORED ADR1,8281,637-191$61,000$29,000-$32,0002017-10-10
Q3 2017NOK
Nokia Corp Sponsored ADR
SPONSORED ADR12,8949,545-3,349$79,000$57,000-$22,0002017-10-10
Q3 2017VOD
Vodafone Group PLC New Sponsored ADR
SPONSORED ADR1,4611,189-272$42,000$34,000-$8,0002017-10-10
Q3 2017DEO
Diageo PLC ADR
SPON ADR NEW1612-4$2,000$2,000$02017-10-10
Q2 2017BUD
Anheuser-Busch InBev SA/NV ADR
SPONSORED ADR2,9142,794-120$320,000$308,000-$12,0002017-07-10
Q2 2017TEVA
Teva Pharmaceutical Industries LTD ADR
SPONSORED ADR2,2831,828-455$73,000$61,000-$12,0002017-07-10
Q1 2017BP
BP P.L.C. Sponsored ADR
SPONSORED ADR5,2284,552-676$196,000$157,000-$39,0002017-04-13

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet